Veracyte Overview
Veracyte Target Price
Analysts' 12-month price predictions for VCYT.
Get informed when a big investor buys or sells
+ FollowShare Price
$56.62
Average Target Price
$52.60
7.1% downside
7.1% downside5 analysts in the last 4 months
High: $65 | Low: $42
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-09 | Morgan Stanley | $47 | 17% downside |  |
| 2026-06-29 | GuggenheimSubbu Nambi | $65 |  14.8% upside | |
| 2026-06-01 | NeedhamMike Matson | $57 | 0.7% upside | |
| 2026-05-06 | UBS | $52 | 8.2% downside | |
| 2026-05-06 | Canaccord GenuityKyle Mikson | $42 | 25.8% downside | |
| 2026-03-05 | Morgan StanleyKallum Titchmarsh | $37 | 34.7% downside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $50 | 11.7% downside | |
| 2025-12-01 | Morgan Stanley | $48 | 15.2% downside | |
| 2025-11-05 | UBSLu Li | $48 | 15.2% downside | |
| 2025-11-05 | Canaccord GenuityKyle Mikson | $43 | 24.1% downside | |
| 2025-10-20 | Canaccord GenuityKyle Mikson | $40 | 29.4% downside | |
| 2025-08-08 | Morgan StanleyTejas Savant | $28 | 50.5% downside | |
| 2024-11-07 | NeedhamMike Matson | $44 | 22.3% downside | |
| 2024-08-12 | Morgan StanleyTejas Savant | $26 | 54.1% downside | |
| 2022-05-04 | Morgan Stanley | $23 | 59.4% downside | |
| 2022-05-04 | Needham | $26 | 54.1% downside | |